EFFECTS OF CS-514 ON SERUM-LIPOPROTEIN LIPID AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA

被引：57
|
作者：
MABUCHI, H
KAMON, N
FUJITA, H
MICHISHITA, I
TAKEDA, M
KAJINAMI, K
ITOH, H
WAKASUGI, T
TAKEDA, R
机构：
来源：
METABOLISM-CLINICAL AND EXPERIMENTAL | 1987年 / 36卷 / 05期
关键词：
D O I：
10.1016/0026-0495(87)90046-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：475 / 479
页数：5
相关论文
共 50 条
  • [21] COMPARATIVE EFFECTS OF SIMVASTATIN (MK-733) AND PRAVASTATIN (CS-514) ON HYPERCHOLESTEROLEMIA INDUCED BY CHOLESTEROL FEEDING IN RABBITS
    ISHIDA, F
    WATANABE, K
    SATO, A
    TAGUCHI, K
    KAKUBARI, K
    KITANI, K
    KAMEI, T
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1042 (03) : 365 - 373
  • [22] TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA - A CONTROLLED TRIAL OF THE EFFECTS OF PRAVASTATIN OR CHOLESTYRAMINE THERAPY ON LIPOPROTEIN AND APOLIPOPROTEIN LEVELS
    WIKLUND, O
    ANGELIN, B
    FAGER, G
    ERIKSSON, M
    OLOFSSON, SO
    BERGLUND, L
    LINDEN, T
    SJOBERG, A
    BONDJERS, G
    JOURNAL OF INTERNAL MEDICINE, 1990, 228 (03) : 241 - 247
  • [23] EFFECTS OF PINACIDIL ON SERUM-LIPID, LIPOPROTEIN, AND APOLIPOPROTEIN LEVELS IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
    SAKU, K
    YING, H
    ARAKAWA, K
    CLINICAL THERAPEUTICS, 1990, 12 (02) : 132 - 138
  • [24] A LONG-TERM EFFECT OF CS-514 (HMG-COA REDUCTASE INHIBITOR) ON SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    SAKU, K
    SASAKI, J
    ARAKAWA, K
    CLINICAL RESEARCH, 1987, 35 (03): : A323 - A323
  • [25] LONG-TERM EFFECT OF CS-514 (HMG-COA REDUCTASE INHIBITOR) ON SERUM-LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
    SAKU, K
    SASAKI, J
    ARAKAWA, K
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 42 (03): : 491 - 500
  • [26] RELATION OF SERUM LIPOPROTEIN(A) CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE TO CORONARY HEART-DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    SEED, M
    HOPPICHLER, F
    REAVELEY, D
    MCCARTHY, S
    THOMPSON, GR
    BOERWINKLE, E
    UTERMANN, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (21): : 1494 - 1499
  • [27] EFFECTS OF SIMVASTATIN ON PLASMA-LIPID, LIPOPROTEIN AND APOLIPOPROTEIN CONCENTRATIONS IN HYPERCHOLESTEROLEMIA
    MOLGAARD, J
    VONSCHENCK, H
    OLSSON, AG
    EUROPEAN HEART JOURNAL, 1988, 9 (05) : 541 - 551
  • [28] Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia
    Carmena-Ramón, R
    Real, JT
    Ascaso, JF
    Ordovás, JM
    Carmena, R
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2000, 10 (01) : 7 - 13
  • [29] EFFECTS OF FISH-OIL ON SERUM-LIPIDS AND LIPOPROTEIN(A) LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    SALVI, A
    DISTEFANO, O
    SLEIMAN, I
    SPANDRIO, S
    BALESTRIERI, GP
    SCALVINI, T
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 53 (06): : 717 - 721
  • [30] INVERSE RELATIONSHIP BETWEEN SERUM LIPOPROTEIN(A) LEVELS AND CHOLESTEROL EFFLUX CAPACITY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Ogura, Masatsune
    Harada-Shiba, Mariko
    ATHEROSCLEROSIS, 2024, 395
12345